BackRapid Dose Therapeutics Overview

Rapid Dose Therapeutics Receivables

Track Rapid Dose Therapeutics's receivables ($130K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$133311.00
↓ 80.56% YoYΔ $-552602.00 vs prior year quarter

Peer trimmed avg / median

Loading

Rapid Dose Therapeutics Receivables History

Loading

Rapid Dose Therapeutics vs. peers: Receivables Comparison

Loading

Rapid Dose Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rapid Dose Therapeutics (DOSE.CN) FAQ

As of the most recent data (August 2026), DOSE.CN shows a receivables of $130K. That compares with $690K in the prior-year period — down 80.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DOSE.CN's receivables is now $130K (was $690K) — a 80.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rapid Dose Therapeutics is outperforming or lagging.

Tracking DOSE.CN's receivables over time shows whether Rapid Dose Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $130K That compares with $690K in the prior-year period — down 80.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Rapid Dose Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $130K) with ownership activity and broader fundamentals.

Rapid Dose Therapeutics's receivables is $130K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.